moa tirzepatide mounjaro mechanism of action Bumps and humps in the success of Tirzepatide as the first GLP1 and GIP receptor agonist Tirzepatide - Wikipedia

Its prescribing information covers glycemic control in adults with type 2 diabetes, cardiovascular risk reduction in adults with type 2 diabetes and established cardiovascular disease, and kidney outcomes in adults with type 2 diabetes and chronic kidney disease

Drug Des Devel Ther 19:56455652 Wang Y, Lan B, Zhang S, Mu Y, Mi J, Yu J et al (2025) Dionysus or apollo, skeletal muscle mass changes in type 2 diabetes with sarcopenia receiving GLP-1 receptor agonist: systematic review and meta-analysis

By improving insulin receptor signalling and promoting glucose metabolism in liver tissues, it helps address a fundamental aspect of NAFLD pathophysiology

GLP-1, a crucial peptide produced in the small intestine, plays a significant role in weight management

GLP-1 (glucagon-like peptid-1) GIP (gastric inhibitory polypeptide) , GLP-1